Refractory neuropathic pain: The nature and extent of the problem

Pain Practice

Volumn 6, Issue 1, 2006, Pages 3-9

  Niv, David ^a   Devor, Marshall ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; CAPSAICIN; LOCAL ANESTHETIC AGENT; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANALGESIA; CLINICAL TRIAL; COMPLEX REGIONAL PAIN SYNDROME; DISEASE SEVERITY; DRUG EFFICACY; EDITORIAL; HUMAN; INCIDENCE; NAUSEA; NERVE INJURY; NEUROLYSIS; NEUROMODULATION; NEUROPATHIC PAIN; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PREVALENCE; SEDATION; SIDE EFFECT; SOMNOLENCE; STATISTICAL SIGNIFICANCE; THERAPY RESISTANCE;

ANALGESICS; AXONS; CENTRAL NERVOUS SYSTEM; HUMANS; HYPERALGESIA; MECHANORECEPTORS; NEURAL CONDUCTION; NEURALGIA; NOCICEPTORS; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 33646704707     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2006.00052.x     Document Type: Editorial

References (31)

1. Merskey H, Bogduk N. Classification of Chronic Pain. Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. Seattle, WA: IASP Press; 1994: 209-213.
2. Dyck PJ, Thomas PK, Griffin JW, Low PA, Podulso JF. Peripheral Neuropathy, 3rd ed. Philadelphia, PA: Saunders; 1993; 1740.
3. Jensen TS, Krebs B, Nielsen J, Rasmussen P. Immediate and long-term phantom limb pain in amputees: Incidence, clinical characteristics and relationship to pre-amputation limb pain. Pain. 1985; 21: 267-278.
4. Andersen G, Vestergaard K, Ingeman-Nielsen M, Jensen TS. Incidence of central post stroke pain. Pain. 1995; 61: 187-193.
5. Osterberg A, Boivie J, Thuomas K-A. Central pain in multiple sclerosis - prevalence and clinical characteristics. Eur J Pain. 2005; 9: 531-542.
6. Boivie J. Central pain. In: Merskey H, Loeser JD, Dubner R, eds. The Paths of Pain. Seattle, WA: IASP Press; 2005; 299-307.
7. Niv D, Meltzman-Tseikin A, Lang E. Postherpetic neuralgia: What do we know and where are we heading? Pain Physician. 2004; 7: 239-247.
8. Verdugo RJ, Bell LA, Campero M, et al. Spectrum of cutaneous hyperalgesias/allodynias in neuropathic pain patients. Acta Neurol Scand. 2004; 110: 368-376.
9. Harden RN, Baron R, Janig WE. Complex Regional Pain Syndrome. Progress in Pain Research and Management, Vol. 22. Seattle, WA: IASP Press; 2001: 338.
10. Hansson P, Lacerenza M, Marchettini P. Aspects of clinical and experimental neuropathic pain: The clinical perspective. In: Hansson PT, Fields H, Hill RG, Marchettini P, eds. Neuropathic Pain Pathophysiology and Treatment Progress in Pain Research and Management, Vol. 21. Seattle, WA: IASP Press; 2001: 1-18.
11. IASP Special Interest Group on Neuropathic Pain. Neuropathic pain - changing paradigms in diagnosis and treatment. Neuropathic Pain Congress, Madrid, Spain, May 13-16, 2004.
12. Devor M. Response of nerves to injury in relation to neuropathic pain. In: McMahon SL, Koltzenburg M, eds. Wall and Melzack's Textbook of Pain, 5th ed. London: Churchill Livingstone; 2005: 905-927.
13. Campbell JN, Raja SN, Meyer RA, MacKinnon SE. Myelinated afferents signal the hyperalgesia associated with nerve injury. Pain. 1988; 32: 89-94.
14. Torebjork H, Lundberg L, LaMotte R. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J Physiol (Lond). 1992; 448: 765-780.
15. Elliott AM, Smith BH, Penny KI, Smith WC, Chambers WA. The epidemiology of chronic pain in the community. Lancet. 1999; 354: 1248-1252.
16. Harstall C, Ospina M. Prevalence of chronic pain. In: Carr D, ed. Clinical Updates. Seattle, WA: IASP Press; 2003; 11: 2.
17. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe. Prevalence, impact on daily life, and treatment. Eur J Pain. In press.
18. Taylor R. Epidemiology of refractory neuropathic pain. Pain Pract. 2006; 6: 22-26.
19. Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain. 2004; 5: 143-149.
20. Johnson L, Regaard A, Herrington N. Pain in general medical patients: An audit. In: Dostrovsky JO, Carr DB, Kolzenburg M, eds. Proceedings of the 10th World Congress on Pain Progress in Pain Research and Management, Vol. 24. Seattle, WA: IASP Press; 2003: 577-586.
21. Montero J, Gutierrez-Rivas E, Pardo J, Navarro C. Epidemiological study of prevalence, incidence and neuropathic pain characterization in neurology units. Prevadol study. Neurologia. 2005; 20: 385-389.
22. Becker N, Bondegaard Thomsen A, Olsen AK, Sjogren P, Bech P, Eriksen J. Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center. Pain. 1997; 73: 393-400.
23. Bowsher D. Neurogenic pain syndromes. Br Med Bull. 1991; 47: 644-666.
24. Ekter-Andersen J, Janzon L, Sjolund B. Chronic pain and the socio-demographic environment: Results from the pain clinic at Malmo General Hospital in Sweden. Clin J Pain. 1993; 9: 183-188.
25. Polydefkis M, Griffin JW, McArthur J. New insights into diabetic polyneuropathy. JAMA. 2003; 290: 1371-1376.
26. London J, London NJ, Kay SP. Iatrogenic accessory nerve injury. Ann R Coll Surg Engl. 1996; 78: 146-150.
27. Huang JH, Zager EL. Thoracic outlet syndrome. Neurosurgery. 2004; 55: 897-902; discussion 902-903.
28. Freeman R. Autonomic peripheral neuropathy. Lancet. 2005; 365: 1259-1270.
29. Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003; 60: 1524-1534.
30. Rowbotham MC, Twilling L, Davies PS, Reisner L, Taylor K, Mohr D. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med. 2003; 348: 1223-1232.
31. Kohno T, Ji RR, Ito N, et al. Peripheral axonal injury results in reduced mu opioid receptor pre- and post-synaptic action in the spinal cord. Pain. 2005; 117: 77-87.